If we look at one gage of satisfaction we see that our renewal rates for the second quarter were 108% based on FTEs and 102% based on contract value. The trailing four quarter period ended June 30, 2012 customers representing 99% of subscribers that were up for renewal did indeed renew while renewal based on contract value over the same four quarter period was 102%.Turning our attention to revenues from our patient survey business which is the recurring revenue of survey product, revenue from that product line increased 7% over the prior quarter. Growth in the patient surveys however was offset by a decline in what we call our point in time surveys which include our physician, employee, and community surveys which resulted in overall research product group revenue decrease of 1% for the quarter. Clearly not at expectations.
HealthStream's CEO Discusses F2Q12 Earnings Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.